Search for: "Lisa Larrimore Ouellette" Results 1 - 20 of 163
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2022, 6:43 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]
3 Mar 2022, 6:43 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsSince the pandemic began, numerous recovered COVID-19 patients have reported having “long COVID”: COVID-19 symptoms persisting well beyond the underlying viral infection period. [read post]
17 Feb 2022, 3:30 am by Lisa Larrimore Ouellette
Lisa Larrimore Ouellette Patent and copyright law share what the Supreme Court calls a “historic kinship”: they both grant exclusive rights under the IP Clause to incentivize production of new knowledge goods. [read post]
21 Jan 2022, 8:35 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe FDA has now authorized three vaccines and several treatments (including both monoclonal antibodies and small-molecule drugs) for the prevention and treatment of COVID-19. [read post]
21 Jan 2022, 8:35 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceThe FDA has now authorized three vaccines and several treatments (including both monoclonal antibodies and small-molecule drugs) for the prevention and treatment of COVID-19. [read post]
1 Dec 2021, 2:00 am by Katharine Van Tassel
Lisa Larrimore Ouellette (Stanford Law School), Michael Abramowicz (George Washington University), Daniel J. [read post]
1 Nov 2021, 11:53 am by Jason Rantanen
Masur & Lisa Larrimore Ouellette, Patent Law: Cases, Problems and Materials (2021) Craig A. [read post]
12 Oct 2021, 2:00 am by Katharine Van Tassel
Rachel Sachs (Washington University in Saint Louis) Lisa Larrimore Ouellette (Stanford University) W. [read post]
27 Sep 2021, 7:26 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsHistorically, the United States’ preparedness for a pandemic is like Charles Dudley Warner’s aphorism on the weather: everybody talks about it but no one ever does anything. [read post]
27 Sep 2021, 7:26 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsHistorically, the United States’ preparedness for a pandemic is like Charles Dudley Warner’s aphorism on the weather: everybody talks about it but no one ever does anything. [read post]
27 Aug 2021, 12:18 pm by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn previous blog posts in this series, we have explored the roles different federal agencies, including the NIH, FDA, and CMS, play in the development and distribution of new healthcare technologies in the fight against COVID-19. [read post]
27 Aug 2021, 12:18 pm by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, and Nicholson PriceIn previous blog posts in this series, we have explored the roles different federal agencies, including the NIH, FDA, and CMS, play in the development and distribution of new healthcare technologies in the fight against COVID-19. [read post]
3 Jun 2021, 8:56 am by Lisa Larrimore Ouellette
Sherkow, Lisa Larrimore Ouellette, Nicholson Price, and Rachel SachsRecently, Pfizer and BioNTech and Moderna announced that they are seeking full FDA approval for their mRNA COVID-19 vaccines—filing, in FDA parlance, a Biologics License Application (BLA). [read post]